Testosterone levels and sexual function disorders in depressive female patients: Effects of antidepressant treatment

Journal of Sexual Medicine

Volumn 11, Issue 2, 2014, Pages 529-535

  Kumsar, Şükrü ^a   Kumsar, Neslihan Akkişi ^a   Sağlam, Hasan Salih ^a   Köse, Osman ^a   Budak, Salih ^a   Adsan, Öztuğ ^a  

^a SAKARYA UNIVERSITY   (Turkey)

Author keywords

Antidepressant Treatment; Depression; Sexual Dysfunction; Testosterone; Women

Indexed keywords

ALBUMIN; SERTRALINE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ANTIDEPRESSANT AGENT;

ADULT; ARIZONA SEXUAL EXPERIENCE SCALE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMALE SEXUAL DYSFUNCTION; GENITAL SYSTEM DISEASE ASSESSMENT; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PREMENOPAUSE; PRIORITY JOURNAL; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; ADOLESCENT; ANTIDEPRESSANT TREATMENT; BLOOD; DEPRESSION; DRUG EFFECT; MIDDLE AGED; PSYCHOSEXUAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; YOUNG ADULT;

ANTIDEPRESSANT TREATMENT; DEPRESSION; SEXUAL DYSFUNCTION; TESTOSTERONE; WOMEN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MIDDLE AGED; PREMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; YOUNG ADULT;

EID: 84907073723     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12394     Document Type: Article

References (34)

1. Kartalci S. Testosterone and depression. Curr Approaches Psychiatry 2010;2:457-472.
2. Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC, Palmer BW, Patterson TL, Reynolds CF 3rd, Lebowitz BD. Consensus statement on the upcoming crisis in geriatric mental health. Arch Gen Psychiatry 1999;56:848-853.
3. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-694.
4. Morales AJ, Nolan JJ, Nelson JC. Effects of replacement doses of DHEA in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-1367.
5. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
6. Seidman SN. Testosterone deficiency and mood in aging men: Pathogenic and therapeutic interactions. World J Biol Psychiatry 2003;4:14-20.
7. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-2098.
8. Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Affect Disord 2003;74:67-83.
9. Rako S. The hormone of desire: The truth about testosterone, sexuality and menopause. New York: Three Rivers Press; 1999.
10. Sherwin BB, Gelfand MM. Differential symptom response to parental estrogen and androgen in the surgical menopause. Am J Obstet Gynecol 1985;151:153-160.
11. Warnock JK, Bundren JC, Morris DW. Depressive symptoms associated with gonadotropin-releasing hormone agonists. Depress Anxiety 1998;7:171-177.
12. Marshall JC. Obesity in adolescent girls: Is excess androgen the real bad actor? J Clin Endocrinol Metab 2006;91:393-395.
13. Eriksson E, Sunblad C, Lisjo P, Modigh K, Andersch B. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992;17:195-204.
14. Hohlagschwandtner M, Husslein P, Klier C, Ulm B. Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand 2001;80:326-330.
15. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006;11:613-625.
16. Giltay EJ, Enter D, Zitman FG, Penninx BW, van Pelt J, Gooren LJG, Spinhoven P, Roelofs K. Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J Psychosom Obstet Gynaecol 2011;32:104-111.
17. Rohr UD. The impact of testosterone imbalance on depression and women's health. Maturitas 2002;41(suppl 1):25-46.
18. Booth A, Johnson DR, Grainger DA. Testosterone and men's depression: The role of social behavior. J Health Soc Behav 1999;40:130-140.
19. Hutchison JB, Steimer TH. Preoptic formation of 17β-oestradiol is influenced by behavioural stimuli in the dove. Brain Res 1985;360:366-369.
20. Katz S, Morales AJ. Dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEAS) as therapeutic options in menopause. Semin Reprod Endocrinol 1998;16:161-170.
21. Davies SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab 2001;12:33-37.
22. Drake EB, Henderson VW, Stanczyk FZ, McCleary CA, Brown WS, Smith CA, Rizzo AA, Murdock GA, Buckwalter JG. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 2000;54:599-603.
23. Carson PR, Elkland-Hirsch KE, Buster JE. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90:995-998.
24. Davis SR, Braunstein GD. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2012;9:1134-1148.
25. Burger H, Hailes J, Nelson J, Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J (Clin Res Ed) 1987;294:936-937.
26. Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward personalized sexual medicine (part 2): Testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. J Sex Med 2013;10:810-823.
27. van Rooij K, Poels S, Bloemers J, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward personalized sexual medicine (part 3): Testosterone combined with a serotonin-1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. J Sex Med 2013;10:824-837.
28. Baldwin DS. Depression and sexual dysfunction. Br Med Bull 2001;57:81-89.
29. Casper RC, Redmond E, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorders: Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098-1104.
30. Gitlin MJ. Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994;55:406-413.
31. Meltzer HY, Young M, Metz J, Fang VS, Schyve PM, Arora RC. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979;45:165-175.
32. Baldessarini RJ, Marsh E. Fluoxetine and side effects. Arch Gen Psychiatry 1990;47:191-192.
33. Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev 1987;11:365-389.
34. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: Influences on male sexual behavior. Physiol Behav 2004;83:291-307.